These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23800548)

  • 1. Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging.
    Nelson MD; Victor RG; Szczepaniak EW; Simha V; Garg A; Szczepaniak LS
    Am J Cardiol; 2013 Oct; 112(7):1019-24. PubMed ID: 23800548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes.
    Levelt E; Mahmod M; Piechnik SK; Ariga R; Francis JM; Rodgers CT; Clarke WT; Sabharwal N; Schneider JE; Karamitsos TD; Clarke K; Rider OJ; Neubauer S
    Diabetes; 2016 Jan; 65(1):44-52. PubMed ID: 26438611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    Nguyen ML; Sachdev V; Burklow TR; Li W; Startzell M; Auh S; Brown RJ
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4327-e4339. PubMed ID: 34223895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric hypertrophic cardiomyopathy in generalized lipodystrophy.
    Scatteia A; Pagano C; Pascale C; Guarini P; Marotta G; Perrone-Filardi P; Bucciarelli-Ducci C; Dellegrottaglie S
    Int J Cardiol; 2016 Jan; 202():724-5. PubMed ID: 26474464
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac Alterations in Patients with Familial Lipodystrophy.
    Romano MMD; Chacon PAI; Ramalho FNZ; Foss MC; Schmidt A
    Arq Bras Cardiol; 2020 Feb; 114(2):305-312. PubMed ID: 32215503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study.
    Akinci G; Topaloglu H; Demir T; Danyeli AE; Talim B; Keskin FE; Kadioglu P; Talip E; Altay C; Yaylali GF; Bilen H; Nur B; Demir L; Onay H; Akinci B
    Neuromuscul Disord; 2017 Oct; 27(10):923-930. PubMed ID: 28754454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac steatosis in patients with dilated cardiomyopathy.
    Granér M; Pentikäinen MO; Nyman K; Siren R; Lundbom J; Hakkarainen A; Lauerma K; Lundbom N; Nieminen MS; Petzold M; Taskinen MR
    Heart; 2014 Jul; 100(14):1107-12. PubMed ID: 24763492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis.
    Mahmod M; Bull S; Suttie JJ; Pal N; Holloway C; Dass S; Myerson SG; Schneider JE; De Silva R; Petrou M; Sayeed R; Westaby S; Clelland C; Francis JM; Ashrafian H; Karamitsos TD; Neubauer S
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):808-16. PubMed ID: 23833283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
    Hussain I; Patni N; Ueda M; Sorkina E; Valerio CM; Cochran E; Brown RJ; Peeden J; Tikhonovich Y; Tiulpakov A; Stender SRS; Klouda E; Tayeh MK; Innis JW; Meyer A; Lal P; Godoy-Matos AF; Teles MG; Adams-Huet B; Rader DJ; Hegele RA; Oral EA; Garg A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1005-1014. PubMed ID: 29267953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac steatosis and left ventricular function in men with metabolic syndrome.
    Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
    J Cardiovasc Magn Reson; 2013 Nov; 15(1):103. PubMed ID: 24228979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular involvement in right ventricular dysplasia/cardiomyopathy.
    Lobo FV; Silver MD; Butany J; Heggtveit HA
    Can J Cardiol; 1999 Nov; 15(11):1239-47. PubMed ID: 10579739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment.
    Lupsa BC; Sachdev V; Lungu AO; Rosing DR; Gorden P
    Medicine (Baltimore); 2010 Jul; 89(4):245-250. PubMed ID: 20616664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
    Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly with congenital generalized lipodystrophy - two rare insulin resistance conditions in one patient: a case report.
    Guerreiro V; Bernardes I; Pereira J; Silva RP; Fernandes S; Carvalho D; Freitas P
    J Med Case Rep; 2020 Feb; 14(1):34. PubMed ID: 32079542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
    Zhou H; Lei X; Yan Y; Lydic T; Li J; Weintraub NL; Su H; Chen W
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31185001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.
    Sai E; Shimada K; Yokoyama T; Hiki M; Sato S; Hamasaki N; Maruyama M; Morimoto R; Miyazaki T; Fujimoto S; Tamura Y; Aoki S; Watada H; Kawamori R; Daida H
    Heart Vessels; 2017 Feb; 32(2):166-174. PubMed ID: 27142065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.